Stocks Stall as US Reopens; SPX, TSLA Mixed, Yields Up

Published on: Nov 13, 2025
Author: Maya Trent

US stock futures turned indecisive as Washington reopened after a record 43-day shutdown, removing one political tail risk but exposing a clouded interest-rate path. The House passed a stopgap funding bill 222-209, restoring back pay to federal employees and keeping key departments open through January 30, 2026. Treasury yields edged higher as investors braced for heavier supply and an uncertain Federal Reserve path, while growth stocks struggled to extend gains. With the government back online and inflation data looming, traders are recalibrating around the real shock: the shutdown’s drag on consumers and a higher-for-longer rates regime that refuses to break.

Rate path stays murky even as Washington reopens

Markets got clarity on the lights staying on. They did not get clarity on rates. The shutdown’s end removes the near-term risk of missed data and delayed auctions, but it also clears the way for Treasury to rebuild cash balances and for the Fed to shift back to reading clean economic prints. Investors are weighing sticky services inflation against softening goods prices and the risk that the shutdown’s demand hit shows up just as the Fed is trying to gauge momentum. Fed officials remain data dependent, but the bar for near-term easing is high with unemployment still historically low and wages elevated. In this tape, every basis point matters for stretched equity multiples.

Treasury supply and yields test equity valuations

The Treasury Department is expected to step up bill issuance to refill the government’s cash account now that a funding deal is in place. That supply, layered on top of ongoing quantitative tightening, pulls in buyers at a price. Higher term premiums push yields up across the curve, pressuring long-duration assets and the mega-cap cohort that led 2025. Exchange-traded funds tied to long bonds such as TLT remain a tell. If yields grind higher on supply rather than growth, the equity market’s valuation cushion thins without the offset of stronger earnings. Banks and insurers can live with higher rates; unprofitable growth and richly priced AI beneficiaries cannot. The reopening relief trade hits a wall if the cost of capital keeps rising.

Shutdown damage bleeds into holiday spending

The shutdown was not just a political story. About 1.25 million federal employees missed paychecks, amounting to roughly $16 billion in lost wages. Back pay is coming for federal workers, but roughly 5.2 million federal contractors are unlikely to be made whole. That is a direct hit to discretionary spending as the holidays begin. Big-box retailers and e-commerce platforms may have to lean harder on promotions to pull in price-sensitive customers whose savings cushions are already thinner than last year. Credit card delinquencies have ticked up from pandemic-era lows, and retailer commentary has tilted cautious on higher-ticket items. If consumer spending underperforms into December, earnings revisions will need to catch down, not up.

Airlines and travel reset will not be instant

Airlines absorbed an estimated $2.6 billion revenue hit as the shutdown rippled through airports, with more than 7,500 flights canceled and staffing stretched. Reopening restores the flow of Transportation Security Administration and air traffic operations, but the backlog on training, certifications, and maintenance is not solved overnight. Carriers have been banking on steady business travel and resilient leisure demand to balance fuel volatility; that calculus gets harder if the consumer softens and corporate budgets stay tight. Hotel operators and booking platforms also face a slower normalization curve, even with pent-up travel demand. Stocks in the complex tend to be rate-sensitive by way of debt loads and capital plans, tying them back to the same yield story that is vexing tech.

Healthcare shifts to center stage with ACA subsidy risk

The funding deal punted on Democrats’ push to extend enhanced Affordable Care Act subsidies, now set to expire in December. Senate Republicans agreed to a vote, but there is no clear support from the White House. That uncertainty lands right in open enrollment season and leaves managed care names like UNH, HUM, and CVS in the crosshairs. If subsidies lapse, exchange enrollment could drop and churn could rise, impacting member mix and margins. Hospitals may see pressure on elective procedures and bad debt. The market will price in policy risk quickly; health insurers thrive on clarity, and December’s vote is a binary catalyst. For investors, this is less a partisan fight and more a margin math problem.

Tech leadership cools as AI trade meets macro reality

The market’s leadership has been narrow and expensive, concentrated in megacaps and AI winners. That trade works when yields are stable or falling. When bond supply pushes term premiums up, the present value math clips multiples fast. Tesla, a bellwether for risk appetite and consumer rate sensitivity, tends to whipsaw on yield spikes, pulling high-beta peers along for the ride. Cloud budgets and AI infrastructure spending are real, but they do not immunize earnings from a higher discount rate. Watch reaction in semis and hyperscale-exposed names to any backup in yields. If tech underperforms on a reopening day, it suggests the market is re-ranking cash flows, not buying headlines.

Cybersecurity funding returns, but procurement lags

The stopgap bill restores funding through January 2026 for key federal cybersecurity programs, including the Cybersecurity Information Sharing Act and the Federal Cybersecurity Enhancement Act. That is a tailwind for vendors with federal exposure such as PANW, CRWD, and FTNT. Still, a multi-week shutdown disrupts procurement cycles and pushes awards into later quarters. Smaller contractors, many of whom will not receive back pay, will have to manage cash tightly, which could defer sub-awards and elongate sales cycles. The strategic demand case for security remains intact; the tactical timing is messier. For now, investors should expect a backlog build that benefits the second half of fiscal 2026 rather than a clean snapback this quarter.

Next catalysts: inflation data, refunding, and December politics

With Washington back, the calendar gets crowded fast. Inflation and retail sales prints will reset the macro debate just as Treasury details issuance plans and the Street absorbs heavier auctions. The Fed will be looking at whether the shutdown’s drag shows up in the data or merely shifts spending across months. December’s vote on ACA subsidies adds a policy swing factor for healthcare and consumer stocks. The path for the S&P 500 hinges on whether yields can stabilize even as supply rises. Relief from reopening is not a reason to chase. It is a cue to rerun the math on margins, multiples, and the cost of capital before the next data point hits.

Clean Energy Cobalt Consumer Products and Services